Insider trades
James Wilbur, Chief Officer of 10x Genomics TXG, has filed 0 purchases and 4 sales on the open market. The latest trade was on 23/11/22.
James Wilbur
Chief Commercial Officer
- Company
- 10x Genomics TXG
- First filing
- 23/03/23
- Trades
- 7 trades
- Buys / sales
- 0 / 4
- 12-month net buying
- No record
- Last trade
- 23/11/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
10x GenomicsTXG | Open-market sale | 23/11/22 | 23/11/27 | 3,464 sh | $43.34 | $150,129.76 | −4.0% |
10x GenomicsTXG | Open-market sale | 23/11/20 | 23/11/22 | 14,718 sh | $42.09 | $619,480.62 | −14.5% |
10x GenomicsTXG | Open-market sale | 23/08/22 | 23/08/24 | 9,699 sh | $45.78 | $444,020.22 | −8.7% |
10x GenomicsTXG | Open-market sale | 23/05/23 | 23/05/25 | 316 sh | $55.07 | $17,402.12 | −0.3% |